Sarinnapha Vasunilashorn, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 28 | 2024 | 1667 | 5.380 |
Why?
|
C-Reactive Protein | 11 | 2021 | 3821 | 1.470 |
Why?
|
Postoperative Complications | 19 | 2024 | 15634 | 1.340 |
Why?
|
Apolipoproteins E | 5 | 2020 | 1443 | 1.330 |
Why?
|
Confusion | 2 | 2020 | 278 | 1.050 |
Why?
|
Geriatric Assessment | 4 | 2023 | 1409 | 0.840 |
Why?
|
Psychometrics | 4 | 2022 | 3061 | 0.790 |
Why?
|
Indians, South American | 2 | 2011 | 34 | 0.740 |
Why?
|
Mobility Limitation | 3 | 2014 | 408 | 0.650 |
Why?
|
Severity of Illness Index | 9 | 2023 | 15845 | 0.640 |
Why?
|
Taiwan | 7 | 2018 | 521 | 0.620 |
Why?
|
Activities of Daily Living | 5 | 2014 | 2420 | 0.610 |
Why?
|
Epistasis, Genetic | 1 | 2020 | 350 | 0.580 |
Why?
|
Inflammation | 8 | 2022 | 10758 | 0.570 |
Why?
|
Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.540 |
Why?
|
Stress, Psychological | 4 | 2014 | 4488 | 0.490 |
Why?
|
Aged | 47 | 2024 | 169266 | 0.480 |
Why?
|
Apolipoprotein E4 | 2 | 2020 | 709 | 0.480 |
Why?
|
Apolipoprotein E2 | 1 | 2015 | 135 | 0.480 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1027 | 0.470 |
Why?
|
Proteomics | 6 | 2024 | 3836 | 0.460 |
Why?
|
Walking | 2 | 2013 | 1194 | 0.450 |
Why?
|
Disability Evaluation | 2 | 2013 | 1834 | 0.450 |
Why?
|
Aged, 80 and over | 24 | 2024 | 58946 | 0.450 |
Why?
|
Cytokines | 3 | 2019 | 7386 | 0.450 |
Why?
|
Widowhood | 1 | 2013 | 52 | 0.440 |
Why?
|
Interview, Psychological | 1 | 2016 | 809 | 0.420 |
Why?
|
Metabolism | 1 | 2014 | 193 | 0.410 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2020 | 6011 | 0.400 |
Why?
|
Body Weight | 2 | 2013 | 4618 | 0.400 |
Why?
|
Health Status | 3 | 2014 | 4077 | 0.390 |
Why?
|
Marriage | 1 | 2013 | 349 | 0.390 |
Why?
|
Nutrition Surveys | 4 | 2021 | 1722 | 0.370 |
Why?
|
Anabolic Agents | 1 | 2014 | 256 | 0.370 |
Why?
|
Parasitic Diseases | 1 | 2010 | 76 | 0.350 |
Why?
|
Wisconsin | 3 | 2016 | 122 | 0.350 |
Why?
|
Lipids | 3 | 2011 | 3330 | 0.350 |
Why?
|
Life Change Events | 1 | 2014 | 952 | 0.320 |
Why?
|
Aging | 6 | 2021 | 8701 | 0.320 |
Why?
|
Female | 50 | 2024 | 392458 | 0.310 |
Why?
|
Prospective Studies | 14 | 2023 | 54419 | 0.300 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8601 | 0.290 |
Why?
|
Male | 46 | 2024 | 360675 | 0.290 |
Why?
|
Telomere | 1 | 2014 | 938 | 0.290 |
Why?
|
Interleukin-6 | 3 | 2022 | 3210 | 0.290 |
Why?
|
Perception | 1 | 2013 | 1198 | 0.270 |
Why?
|
Stress, Physiological | 1 | 2014 | 1406 | 0.260 |
Why?
|
Disabled Persons | 2 | 2013 | 1226 | 0.260 |
Why?
|
Humans | 62 | 2024 | 761098 | 0.260 |
Why?
|
Phenotype | 1 | 2023 | 16572 | 0.250 |
Why?
|
Incidence | 7 | 2023 | 21357 | 0.250 |
Why?
|
Body Mass Index | 5 | 2016 | 12951 | 0.250 |
Why?
|
Longitudinal Studies | 9 | 2018 | 14607 | 0.240 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1885 | 0.240 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.230 |
Why?
|
Morbidity | 1 | 2010 | 1750 | 0.230 |
Why?
|
Mental Health | 2 | 2016 | 3251 | 0.230 |
Why?
|
Postural Balance | 1 | 2009 | 623 | 0.230 |
Why?
|
Health Surveys | 2 | 2011 | 4036 | 0.230 |
Why?
|
Vision Disorders | 1 | 2011 | 1088 | 0.220 |
Why?
|
Proteome | 3 | 2022 | 1856 | 0.210 |
Why?
|
Depressive Disorder | 1 | 2016 | 3727 | 0.210 |
Why?
|
Logistic Models | 7 | 2020 | 13254 | 0.210 |
Why?
|
Orthopedic Procedures | 3 | 2022 | 1276 | 0.210 |
Why?
|
Frail Elderly | 2 | 2023 | 765 | 0.210 |
Why?
|
Risk Factors | 13 | 2024 | 74219 | 0.210 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20120 | 0.200 |
Why?
|
Communicable Diseases | 1 | 2011 | 873 | 0.200 |
Why?
|
Sex Factors | 5 | 2016 | 10552 | 0.200 |
Why?
|
Cyclophosphamide | 3 | 2011 | 2219 | 0.190 |
Why?
|
Lung Diseases, Interstitial | 3 | 2011 | 918 | 0.190 |
Why?
|
Least-Squares Analysis | 2 | 2013 | 368 | 0.190 |
Why?
|
Bolivia | 2 | 2011 | 22 | 0.190 |
Why?
|
Case-Control Studies | 8 | 2024 | 22157 | 0.180 |
Why?
|
Odds Ratio | 4 | 2016 | 9648 | 0.180 |
Why?
|
Osmolar Concentration | 1 | 2021 | 658 | 0.180 |
Why?
|
Hospitalization | 2 | 2020 | 10712 | 0.180 |
Why?
|
Urine | 1 | 2021 | 362 | 0.170 |
Why?
|
Italy | 2 | 2013 | 843 | 0.160 |
Why?
|
Scleroderma, Diffuse | 2 | 2008 | 18 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17889 | 0.160 |
Why?
|
Genotype | 4 | 2020 | 12983 | 0.150 |
Why?
|
Mortality | 1 | 2010 | 2896 | 0.150 |
Why?
|
Alleles | 3 | 2020 | 6857 | 0.150 |
Why?
|
Neurofilament Proteins | 1 | 2020 | 334 | 0.150 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39121 | 0.150 |
Why?
|
Scleroderma, Systemic | 1 | 2011 | 344 | 0.140 |
Why?
|
Albuminuria | 1 | 2021 | 656 | 0.140 |
Why?
|
Metabolomics | 2 | 2024 | 1658 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3803 | 0.140 |
Why?
|
Dementia | 3 | 2024 | 2682 | 0.140 |
Why?
|
Cognitive Reserve | 1 | 2017 | 91 | 0.140 |
Why?
|
Age Factors | 4 | 2016 | 18385 | 0.130 |
Why?
|
Area Under Curve | 1 | 2020 | 1636 | 0.130 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2015 | 39 | 0.120 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7804 | 0.120 |
Why?
|
Computational Biology | 2 | 2023 | 3499 | 0.110 |
Why?
|
Middle Aged | 16 | 2024 | 220835 | 0.110 |
Why?
|
Respiratory Function Tests | 2 | 2013 | 1685 | 0.110 |
Why?
|
Diet | 1 | 2011 | 8047 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2181 | 0.100 |
Why?
|
Risk Assessment | 4 | 2017 | 24013 | 0.100 |
Why?
|
ROC Curve | 1 | 2020 | 3582 | 0.100 |
Why?
|
England | 1 | 2013 | 526 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1388 | 0.100 |
Why?
|
Cohort Studies | 7 | 2021 | 41486 | 0.100 |
Why?
|
Health Behavior | 2 | 2013 | 2641 | 0.100 |
Why?
|
Cultural Characteristics | 1 | 2013 | 250 | 0.100 |
Why?
|
Antirheumatic Agents | 1 | 2011 | 1366 | 0.100 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 4243 | 0.100 |
Why?
|
Spouses | 1 | 2013 | 284 | 0.090 |
Why?
|
Obesity | 1 | 2013 | 12937 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 387 | 0.090 |
Why?
|
Body Weights and Measures | 1 | 2010 | 208 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2011 | 4189 | 0.080 |
Why?
|
Waist Circumference | 1 | 2013 | 933 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2731 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12058 | 0.080 |
Why?
|
Vision, Low | 1 | 2011 | 163 | 0.080 |
Why?
|
Scleroderma, Localized | 1 | 2009 | 87 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2013 | 1597 | 0.080 |
Why?
|
Scleroderma, Limited | 1 | 2008 | 8 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2020 | 7043 | 0.080 |
Why?
|
Nursing Homes | 1 | 2016 | 1083 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3881 | 0.080 |
Why?
|
Homocysteine | 1 | 2011 | 637 | 0.070 |
Why?
|
Sex Ratio | 1 | 2008 | 107 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5828 | 0.070 |
Why?
|
Sampling Studies | 1 | 2009 | 615 | 0.070 |
Why?
|
Length of Stay | 2 | 2021 | 6420 | 0.070 |
Why?
|
Blindness | 1 | 2011 | 585 | 0.070 |
Why?
|
Occupations | 1 | 2009 | 516 | 0.070 |
Why?
|
Risk | 2 | 2017 | 9614 | 0.070 |
Why?
|
Prognosis | 3 | 2021 | 29672 | 0.070 |
Why?
|
Blood Pressure | 2 | 2013 | 8478 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20600 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7034 | 0.060 |
Why?
|
Educational Status | 1 | 2013 | 2510 | 0.060 |
Why?
|
Forecasting | 1 | 2015 | 2928 | 0.060 |
Why?
|
Risk-Taking | 1 | 2011 | 1038 | 0.060 |
Why?
|
Time Factors | 3 | 2016 | 39953 | 0.060 |
Why?
|
Longevity | 1 | 2013 | 1064 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5869 | 0.060 |
Why?
|
Prevalence | 3 | 2021 | 15717 | 0.060 |
Why?
|
Demography | 1 | 2010 | 1643 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5872 | 0.060 |
Why?
|
Overweight | 1 | 2016 | 2418 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2278 | 0.060 |
Why?
|
Cognition | 2 | 2020 | 6987 | 0.060 |
Why?
|
Arteries | 1 | 2009 | 1121 | 0.060 |
Why?
|
Reward | 1 | 2011 | 970 | 0.060 |
Why?
|
Vital Capacity | 2 | 2011 | 970 | 0.060 |
Why?
|
Life Expectancy | 1 | 2011 | 1242 | 0.060 |
Why?
|
Adolescent | 5 | 2021 | 88271 | 0.060 |
Why?
|
Exercise Tolerance | 1 | 2009 | 838 | 0.050 |
Why?
|
Disease Progression | 2 | 2019 | 13506 | 0.050 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.050 |
Why?
|
Infant Mortality | 1 | 2008 | 752 | 0.050 |
Why?
|
Adult | 10 | 2021 | 221083 | 0.050 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1141 | 0.050 |
Why?
|
Societies, Medical | 1 | 2015 | 3923 | 0.050 |
Why?
|
Weight Gain | 1 | 2013 | 2349 | 0.050 |
Why?
|
United States | 4 | 2021 | 72337 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2008 | 589 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1893 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2902 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3268 | 0.050 |
Why?
|
tau Proteins | 2 | 2024 | 2094 | 0.050 |
Why?
|
Life Style | 1 | 2013 | 3908 | 0.050 |
Why?
|
Hypertension | 2 | 2013 | 8537 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6178 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2017 | 5777 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2011 | 2638 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2023 | 563 | 0.040 |
Why?
|
Databases, Factual | 1 | 2016 | 7969 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Adiposity | 1 | 2009 | 1879 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12467 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 3974 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 550 | 0.040 |
Why?
|
Plasma | 1 | 2022 | 586 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10083 | 0.040 |
Why?
|
Quality of Life | 2 | 2019 | 13362 | 0.040 |
Why?
|
Lung Diseases | 1 | 2008 | 1909 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 983 | 0.040 |
Why?
|
Calcinosis | 1 | 2006 | 1477 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14023 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3925 | 0.040 |
Why?
|
Blood Proteins | 1 | 2022 | 1172 | 0.030 |
Why?
|
Expert Testimony | 1 | 2019 | 365 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14676 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15513 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15308 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2006 | 3111 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9317 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.030 |
Why?
|
Depression | 1 | 2013 | 8130 | 0.030 |
Why?
|
Calcium | 1 | 2006 | 5720 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2011 | 12341 | 0.030 |
Why?
|
Atrophy | 1 | 2017 | 1633 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2020 | 1881 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2018 | 982 | 0.020 |
Why?
|
Games, Experimental | 1 | 2011 | 32 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15915 | 0.020 |
Why?
|
Animals | 1 | 2023 | 168083 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3840 | 0.020 |
Why?
|
Executive Function | 1 | 2018 | 1388 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26068 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2019 | 80673 | 0.020 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2008 | 94 | 0.020 |
Why?
|
Total Lung Capacity | 1 | 2008 | 148 | 0.020 |
Why?
|
Pressure | 1 | 2011 | 1152 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42217 | 0.020 |
Why?
|
Vitamin D | 1 | 2021 | 3302 | 0.020 |
Why?
|
Cold Temperature | 1 | 2011 | 783 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2254 | 0.020 |
Why?
|
Caregivers | 1 | 2019 | 2241 | 0.020 |
Why?
|
Catecholamines | 1 | 2008 | 387 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6504 | 0.020 |
Why?
|
Saliva | 1 | 2011 | 828 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8836 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2008 | 241 | 0.020 |
Why?
|
Arabinose | 1 | 2005 | 31 | 0.020 |
Why?
|
Yersinia pestis | 1 | 2005 | 33 | 0.020 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2005 | 106 | 0.020 |
Why?
|
Placebos | 1 | 2009 | 1666 | 0.020 |
Why?
|
Spirometry | 1 | 2008 | 928 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10514 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22125 | 0.010 |
Why?
|
Brain | 1 | 2011 | 27097 | 0.010 |
Why?
|
Etoposide | 1 | 2005 | 634 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6585 | 0.010 |
Why?
|
Catalysis | 1 | 2005 | 763 | 0.010 |
Why?
|
Tryptophan | 1 | 2005 | 480 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2011 | 1818 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1731 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 925 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1303 | 0.010 |
Why?
|
Child | 1 | 2011 | 80134 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1681 | 0.010 |
Why?
|
Magnesium | 1 | 2005 | 804 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2599 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1227 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59199 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2261 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2011 | 64670 | 0.010 |
Why?
|
Oxygen | 1 | 2011 | 4226 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3779 | 0.010 |
Why?
|
Radiography | 1 | 2008 | 6975 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36418 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 5993 | 0.010 |
Why?
|
Skin | 1 | 2009 | 4473 | 0.010 |
Why?
|
Brain Mapping | 1 | 2011 | 6635 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6507 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5413 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9001 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13404 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10755 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9300 | 0.010 |
Why?
|
Escherichia coli | 1 | 2005 | 4205 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17598 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7189 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26187 | 0.000 |
Why?
|
Infant | 1 | 2008 | 36164 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 30006 | 0.000 |
Why?
|